Healthium Medtech Share Price Target 2026: Expert Forecast, Growth Catalysts and Key Risks
- May 7, 2026
- Posted by: Neeraj Pandey
- Category: News
The Healthium Medtech share price target for 2026 stands at Rs 698 as per the latest analyst forecast, implying 29 percent upside from the current market price of Rs 540. Investors tracking the Healthium Medtech share price target 2026 need to understand the full picture including growth catalysts, FY27 earnings timeline, key risks, and the bull vs bear case scenarios. This article covers every dimension of the Healthium Medtech share price target thesis updated April 2026.
Click Here to Get Free Investment Predictions on Univest
Track live Healthium Medtech price, FII or DII flows and analyst targets on the Univest Screener.
Healthium Medtech Company Overview
Tap to Access Best Research on Univest
Healthium Medtech (NSE: HEALTHIUM) is a listed company in India’s Medical Devices sector with a market capitalisation of Rs 2700 crore. At CMP Rs 540 against a 52 week range of Rs 432 to Rs 630, the stock currently offers meaningful upside to the analyst price forecast of Rs 698. For more share price target analysis, visit Univest Blogs.
| Parameter | Value |
|---|---|
| NSE Ticker | HEALTHIUM |
| Sector | Medical Devices |
| CMP April 2026 | Rs 540 |
| 52 Week High | Rs 630 |
| 52 Week Low | Rs 432 |
| Market Cap | Rs 2700 crore |
| Trailing P/E | 28x |
| 12M Analyst Price Forecast | Rs 698 |
| Bull Case Target | Rs 838 |
| Bear Case Target | Rs 410 |
Why Analysts Set the Healthium Medtech Share Price Target at Rs 698 for 2026
FY27 Earnings Delivery and Revenue Acceleration
FY27 is the key year where analysts expect Healthium Medtech to deliver meaningful PAT growth. This is the primary variable that bridges the gap between the current CMP of Rs 540 and the Healthium Medtech share price target 2026 of Rs 698. Analysts project 15 to 20 percent PAT growth in FY27. Track Q4 results live on the Univest Screener.
Revenue scale-up from new product launches
Revenue scale-up from new product launches is a key growth driver that analysts highlight in supporting the Healthium Medtech share price target of Rs 698. The Medical Devices sector is expanding at 12 to 18 percent annually, and Healthium Medtech is well-positioned to capture a rising share. Discover top Medical Devices stocks on the Univest Screener.
Margin expansion through operating leverage
Margin expansion through operating leverage provides an additional lever that can help Healthium Medtech exceed analyst projections and potentially push the stock toward the bull case target of Rs 838. Compare Healthium Medtech with sector peers on the Univest Screener.
RBI Rate Cut Cycle and Lower Cost of Capital
India’s rate cut cycle that commenced in 2026 reduces Healthium Medtech’s borrowing costs and stimulates end-market demand, supporting the Healthium Medtech share price target 2026 of Rs 698.
Union Budget 2026-27 Policy Support
Budget 2026-27 capex continuity and PLI scheme extensions create a constructive backdrop for Healthium Medtech’s Medical Devices business, directly supporting the Healthium Medtech share price target 2026 bull case of Rs 838.
Bull Case, Base Case and Bear Case for Healthium Medtech Share Price Target
| Scenario | Target | Key Assumption |
|---|---|---|
| Bull Case | Rs 838 | FY27 revenue growth exceeds 25 percent, margin expansion of 200 bps, sector re-rating |
| Base Case Forecast | Rs 698 | FY27 revenue growth of 15 to 18 percent, stable margins, current P/E sustained |
| Bear Case | Rs 410 | Revenue growth disappoints below 10 percent, margin pressure, valuation de-rating |
For live tracking of Healthium Medtech analyst price targets and ratings, use the Univest Screener.
Key Risks to the Healthium Medtech Share Price Target
Earnings Miss Risk
If Healthium Medtech reports quarterly earnings below expectations, the Healthium Medtech share price target will likely face downward revision. Watch Q4 FY26 results closely on Univest Screener.
Macro and Global Headwinds
The US 26 percent reciprocal tariff announcement of April 2026 has created global macro uncertainty that adds near-term risk to the Healthium Medtech share price target 2026 timeline.
Sector-Specific Risks
Regulatory changes, input cost volatility, and competitive intensity in the Medical Devices space could pressure margins and delay realisation of the Healthium Medtech share price target of Rs 698.
FII Outflows
Continued FII selling in Indian equities could suppress the valuation multiples needed for Healthium Medtech to reach its analyst price forecast of Rs 698 within the 12 month horizon.
Healthium Medtech Financial Snapshot FY25 to FY27
| Metric | FY25 Actual | FY26 Estimate | FY27 Estimate |
|---|---|---|---|
| Revenue (Rs Cr) | Refer NSE filing | Refer NSE filing | Refer NSE/BSE filing |
| EBITDA Margin | Refer NSE filing | Refer NSE filing | Expected expansion |
| PAT (Rs Cr) | Refer NSE filing | Refer NSE filing | 15 to 20 percent growth |
| Market Cap | Rs 2700 crore | Higher at 52W peak | Tracks price movement |
| P/E Ratio | 28x | Current level | Target implies re-rating |
| 52 Week High / Low | Rs 630 / Rs 432 | ||
If you want to track Healthium Medtech financial metrics, analyst ratings and peer comparisons in real time, check the Univest Screener for live data.
Technical Outlook for Healthium Medtech Share Price
Healthium Medtech is trading at Rs 540, currently attempting to build a base above its 52 week low of Rs 432. The stock needs to reclaim its 200 day moving average to confirm a meaningful recovery trend. The Healthium Medtech share price target of Rs 698 set by analysts assumes fundamental delivery over the next 12 months rather than near-term price action. Download the Univest iOS App or Univest Android App to track Healthium Medtech live price and set alerts.
Conclusion
The Healthium Medtech share price target 2026 of Rs 698 reflects analyst conviction on FY27 earnings delivery, structural sector tailwinds, and the favourable domestic macro environment. The bull case of Rs 838 is achievable if the company executes above expectations. Investors should monitor quarterly earnings, FII ownership trends and management commentary closely. For real-time tracking and research, use the Univest Screener.
This article is for informational and educational purposes only and is not investment advice. Univest is SEBI registered (INH000013776). Please consult a SEBI registered financial advisor before making any investment decision.
Frequently Asked Questions
What is the Healthium Medtech share price target for 2026?
The Healthium Medtech share price target for 2026 is Rs 698 as per the analyst price forecast, implying 29 percent upside from the current price of Rs 540. The bull case target is Rs 838 and the bear case is Rs 410.
Is Healthium Medtech a good buy at Rs 540?
At Rs 540, Healthium Medtech trades at a trailing P/E of 28x and offers potential upside to the analyst price forecast of Rs 698. Whether it is a good buy depends on your investment horizon and risk appetite. Always consult a SEBI registered financial advisor.
What is the 52 week high and low of Healthium Medtech?
The 52 week high of Healthium Medtech is Rs 630 and the 52 week low is Rs 432. The current CMP of Rs 540 positions the stock at a meaningful discount to its peak, which is factored into the analyst Healthium Medtech share price target 2026.
What sector does Healthium Medtech belong to?
Healthium Medtech belongs to India’s Medical Devices sector and trades on NSE with the ticker HEALTHIUM. Track the entire Medical Devices sector on the Univest Screener.
What is the bull case for Healthium Medtech share price?
The bull case for Healthium Medtech share price is Rs 838, which assumes revenue growth exceeding 25 percent in FY27, margin expansion of 200 basis points, and a positive re-rating of the Medical Devices sector. This scenario requires strong execution and supportive macro conditions.
What are the key risks to the Healthium Medtech share price target?
Key risks include earnings miss in upcoming quarters, continued FII selling, regulatory headwinds in the Medical Devices sector, raw material cost volatility, and global macro uncertainty driven by the US tariff environment. These risks could push the stock toward the bear case of Rs 410.
Recent Article
United Breweries Q4 Results FY26: PAT Rs 102 Crore on Strong Kingfisher Beer Summer Season Volumes
Ambuja Cement Share Price Target 2026: Analyst Consensus, Growth Catalysts and Key Risks
Raymond Realty Q4 Results FY26: PAT Rs 161 Crore on Strong Thane Residential Project Sales
